FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133095087> ?p ?o ?g. }

• W3133095087 endingPage "418" @default.
• W3133095087 startingPage "418" @default.
• W3133095087 abstract "Three-dimensionally printed nasopharyngeal swabs (3DP swabs) have been used to mitigate swab shortages during the coronavirus disease 2019 (COVID-19) pandemic. Clinical validation for diagnostic accuracy and consistency, as well as patient acceptability, is crucial to evaluate the swab's performance.To determine the accuracy and acceptability of the 3DP swab for identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).A diagnostic study was conducted from May to July 2020 at 2 tertiary care centers in Singapore with different reference swabs (FLOQSwab [COPAN Diagnostics] or Dacron swab [Deltalab]) and swab processing techniques (wet or dry) to evaluate the performance of the 3DP swab compared with traditional, standard-of-care nasopharyngeal swabs used in health care institutions. The participants were patients with COVID-19 in the first 2 weeks of illness and controls with acute respiratory illness with negative test results for SARS-CoV-2. Paired nasopharyngeal swabs were obtained from the same nostril and tested for SARS-CoV-2 by reverse-transcriptase polymerase chain reaction. The sequence of swabs was randomized based on odd and even participant numbers.Primary outcome measures were overall agreement (OA), positive percentage agreement (PPA), and negative percentage agreement of the 3DP swab compared with reference swabs. Secondary outcome measures were the correlation of cycle threshold (Ct) values of both swabs.The mean (SD) age of participants was 45.4 (13.1) years, and most participants were men (87 of 89 [97.8%]), in keeping with the epidemiology of the COVID-19 pandemic in Singapore. A total of 79 patients with COVID-19 and 10 controls were recruited. Among the patients with COVID-19, the overall agreement and PPA of the 3DP swab was 91.1% and 93.5%, respectively, compared with reference swabs. The PPA was 100% for patients with COVID-19 who were tested within the first week of illness. All controls tested negative. The reverse-transcriptase polymerase chain reaction Ct values for the ORF1ab and E-gene targets showed a strong correlation (intraclass correlations coefficient, 0.869-0.920) between the 3DP and reference swab on independent testing at each institution despite differences in sample processing. Discordant results for both gene targets were observed only at high Ct values.In this diagnostic study of 79 patients with COVID-19 and 10 controls, the 3DP swab performed accurately and consistently across health care institutions and could help mitigate strained resources in the escalating COVID-19 pandemic." @default.
• W3133095087 created "2021-03-01" @default.
• W3133095087 creator A5000269627 @default.
• W3133095087 creator A5005667204 @default.
• W3133095087 creator A5011465991 @default.
• W3133095087 creator A5011495680 @default.
• W3133095087 creator A5018255531 @default.
• W3133095087 creator A5024312276 @default.
• W3133095087 creator A5027629410 @default.
• W3133095087 creator A5032922832 @default.
• W3133095087 creator A5036277565 @default.
• W3133095087 creator A5037998416 @default.
• W3133095087 creator A5039996179 @default.
• W3133095087 creator A5042806754 @default.
• W3133095087 creator A5044897397 @default.
• W3133095087 creator A5046657855 @default.
• W3133095087 creator A5052645908 @default.
• W3133095087 creator A5053363070 @default.
• W3133095087 creator A5054069216 @default.
• W3133095087 creator A5055086360 @default.
• W3133095087 creator A5056289627 @default.
• W3133095087 creator A5060033257 @default.
• W3133095087 creator A5068784002 @default.
• W3133095087 creator A5074624952 @default.
• W3133095087 creator A5074903918 @default.
• W3133095087 creator A5080292717 @default.
• W3133095087 creator A5082807809 @default.
• W3133095087 creator A5083915828 @default.
• W3133095087 creator A5085352143 @default.
• W3133095087 creator A5087360102 @default.
• W3133095087 creator A5090833605 @default.
• W3133095087 creator A5091549169 @default.
• W3133095087 date "2021-05-01" @default.
• W3133095087 modified "2023-10-04" @default.
• W3133095087 title "Design and Multicenter Clinical Validation of a 3-Dimensionally Printed Nasopharyngeal Swab for SARS-CoV-2 Testing" @default.
• W3133095087 cites W1978765295 @default.
• W3133095087 cites W2171327036 @default.
• W3133095087 cites W2327037637 @default.
• W3133095087 cites W3008443627 @default.
• W3133095087 cites W3016317322 @default.
• W3133095087 cites W3016484923 @default.
• W3133095087 cites W3017617595 @default.
• W3133095087 cites W3021552678 @default.
• W3133095087 cites W3023086180 @default.
• W3133095087 cites W3024182635 @default.
• W3133095087 cites W3024634942 @default.
• W3133095087 cites W3025928348 @default.
• W3133095087 cites W3027829318 @default.
• W3133095087 cites W3029288888 @default.
• W3133095087 cites W3035793202 @default.
• W3133095087 doi "https://doi.org/10.1001/jamaoto.2020.5680" @default.
• W3133095087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7893548" @default.
• W3133095087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33599684" @default.
• W3133095087 hasPublicationYear "2021" @default.
• W3133095087 type Work @default.
• W3133095087 sameAs 3133095087 @default.
• W3133095087 citedByCount "6" @default.
• W3133095087 countsByYear W31330950872021 @default.
• W3133095087 countsByYear W31330950872022 @default.
• W3133095087 countsByYear W31330950872023 @default.
• W3133095087 crossrefType "journal-article" @default.
• W3133095087 hasAuthorship W3133095087A5000269627 @default.
• W3133095087 hasAuthorship W3133095087A5005667204 @default.
• W3133095087 hasAuthorship W3133095087A5011465991 @default.
• W3133095087 hasAuthorship W3133095087A5011495680 @default.
• W3133095087 hasAuthorship W3133095087A5018255531 @default.
• W3133095087 hasAuthorship W3133095087A5024312276 @default.
• W3133095087 hasAuthorship W3133095087A5027629410 @default.
• W3133095087 hasAuthorship W3133095087A5032922832 @default.
• W3133095087 hasAuthorship W3133095087A5036277565 @default.
• W3133095087 hasAuthorship W3133095087A5037998416 @default.
• W3133095087 hasAuthorship W3133095087A5039996179 @default.
• W3133095087 hasAuthorship W3133095087A5042806754 @default.
• W3133095087 hasAuthorship W3133095087A5044897397 @default.
• W3133095087 hasAuthorship W3133095087A5046657855 @default.
• W3133095087 hasAuthorship W3133095087A5052645908 @default.
• W3133095087 hasAuthorship W3133095087A5053363070 @default.
• W3133095087 hasAuthorship W3133095087A5054069216 @default.
• W3133095087 hasAuthorship W3133095087A5055086360 @default.
• W3133095087 hasAuthorship W3133095087A5056289627 @default.
• W3133095087 hasAuthorship W3133095087A5060033257 @default.
• W3133095087 hasAuthorship W3133095087A5068784002 @default.
• W3133095087 hasAuthorship W3133095087A5074624952 @default.
• W3133095087 hasAuthorship W3133095087A5074903918 @default.
• W3133095087 hasAuthorship W3133095087A5080292717 @default.
• W3133095087 hasAuthorship W3133095087A5082807809 @default.
• W3133095087 hasAuthorship W3133095087A5083915828 @default.
• W3133095087 hasAuthorship W3133095087A5085352143 @default.
• W3133095087 hasAuthorship W3133095087A5087360102 @default.
• W3133095087 hasAuthorship W3133095087A5090833605 @default.
• W3133095087 hasAuthorship W3133095087A5091549169 @default.
• W3133095087 hasBestOaLocation W31330950871 @default.
• W3133095087 hasConcept C107130276 @default.
• W3133095087 hasConcept C126322002 @default.
• W3133095087 hasConcept C203014093 @default.
• W3133095087 hasConcept C2779134260 @default.
• W3133095087 hasConcept C3007834351 @default.
• W3133095087 hasConcept C3008058167 @default.

• next